Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Felodipine
Matrix: | Human Plasma |
Assay Range: | 0.05 - 10 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Felodipine
Matrix: | Human Plasma |
Assay Range: | 50 - 16,000 pg/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Fenofibric acid
Matrix: | Human Plasma |
Assay Range: | 0.1 - 16 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cholesterol |
Classification: | Drug Assays |
Fenofibric acid
Matrix: | Human Plasma |
Assay Range: | 50 - 50,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cholesterol |
Classification: | Drug Assays |
Fenofibric acid
Matrix: | Human Plasma |
Assay Range: | 20 - 400 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cholesterol |
Classification: | Drug Assays |
Fentanyl
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 pg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Narcotic Analgesic |
Classification: | Drug Assays |
Ferritin
Matrix: | Human Plasma |
Assay Range: | 0.781 - 50.0 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Fexofenadine
Matrix: | Human Plasma |
Assay Range: | 2 - 300 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Fexofenadine
Matrix: | Human Plasma |
Assay Range: | 3 - 2,500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Fexofenadine
Matrix: | Human Plasma |
Assay Range: | 2 - 800 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Fexofenadine
Matrix: | Human Plasma |
Assay Range: | 4 - 1,600 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Fexofenadine Pseudoephedrine
Matrix: | Human Plasma |
Assay Range: | 2 - 2,000 ng/mL 2 - 2,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Fexofenadine Pseudoephedrine
Matrix: | Human Plasma |
Assay Range: | 2 - 800 ng/mL 2 - 800 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Finasteride
Matrix: | Human Plasma |
Assay Range: | 0.4 - 80 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Finasteride
Matrix: | Human plasma |
Assay Range: | 0.200 - 100 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Fluconazole
Matrix: | Human Plasma |
Assay Range: | 50 - 10,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antifungal |
Classification: | Drug Assays |
Fludarabine
Cyclophosphamide
Cyclophosphamide
Matrix: | Human Plasma |
Assay Range: | 2.00 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Fludrocortisone
Matrix: | Human Plasma |
Assay Range: | 40 - 3000 pg/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Fluoxetine
Norfluoxetine
Norfluoxetine
Matrix: | Human Plasma |
Assay Range: | 0.5 - 120 ng/mL0.3 - 72 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Fluoxetine
Norfluoxetine
Norfluoxetine
Matrix: | Human Plasma |
Assay Range: | 0.25 - 100 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Fluvastatin
Matrix: | Human Plasma |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Statin |
Classification: | Drug Assays |
Fluvoxamine
Matrix: | Human Plasma |
Assay Range: | 0.5 - 500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Furosemide
Matrix: | Human Plasma |
Assay Range: | 5 to 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | K2 EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Diuretic |
Classification: | Drug Assays |
Gabapentin
Matrix: | Human Plasma |
Assay Range: | 20 - 20,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Gadolinium
Matrix: | Human Plasma |
Assay Range: | 0.250 - 250 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Diagnostic |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT